These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6515702)

  • 21. Red-cell organic phosphates in patients with chronic renal failure on maintenance haemodialysis.
    Chillar RK; Desforges JF
    Br J Haematol; 1974 Apr; 26(4):549-56. PubMed ID: 4845648
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparability of insulin binding to erythrocytes and monocytes from hemodialysis patients and healthy subjects.
    Briggs WA; Wielechowski KS; Mahajan SK; McDonald FD
    Am J Nephrol; 1981; 1(1):41-4. PubMed ID: 6756142
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of amantadine on L-2-14C-dopa metabolism in parkinsonism.
    Peaston MJ; Bianchine JR; Messiha FS
    Life Sci; 1973 Aug; 13(3):237-46. PubMed ID: 4750920
    [No Abstract]   [Full Text] [Related]  

  • 24. Amantadine-induced serotonin syndrome in a patient with renal failure.
    Cheng PL; Hung SW; Lin LW; Chong CF; Lau CI
    Am J Emerg Med; 2008 Jan; 26(1):112.e5-6. PubMed ID: 18082803
    [No Abstract]   [Full Text] [Related]  

  • 25. Amantadine-induced psychosis in a geriatric patient with renal disease.
    Borison RL
    Am J Psychiatry; 1979 Jan; 136(1):111-2. PubMed ID: 758814
    [No Abstract]   [Full Text] [Related]  

  • 26. The erythrocyte protoporphyrin in chronic renal failure.
    Vlassopoulos K; Melissinos K; Drivas G
    Clin Chim Acta; 1975 Dec; 65(3):389-92. PubMed ID: 1204227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gas-liquid chromatographic determination of plasma and urinary levels of amantadine in man.
    Bélanger PM; Grech-Bélanger O
    J Chromatogr; 1982 Mar; 228():327-32. PubMed ID: 7076756
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship between carbonic anhydrases and zinc concentration of erythrocytes in patients under chronic hemodialysis.
    Goriki K; Wada K; Hata J; Kobayashi M; Hirabayashi A; Shigemoto K; Hamaguchi N; Yorioka N; Yamakido M
    Hiroshima J Med Sci; 1982 Jun; 31(2):123-7. PubMed ID: 6813298
    [No Abstract]   [Full Text] [Related]  

  • 29. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse.
    Rees WA; Harkins JD; Woods WE; Blouin RA; Lu M; Fenger C; Holland RE; Chambers TM; Tobin T
    Equine Vet J; 1997 Mar; 29(2):104-10. PubMed ID: 9104558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oxygen affinity of haemoglobin in chronic renal disease (author's transl)].
    Humpeler E; Amor H; Dittrich P
    Dtsch Med Wochenschr; 1974 Apr; 99(15):742-5. PubMed ID: 4834838
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in the plasma and erythrocyte concentrations of rubidium in patients with renal failure].
    Allain P; Mauras Y; Tafforeau C; Houssin A; Cartier F
    Presse Med; 1984 Oct; 13(37):2249-51. PubMed ID: 6239169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red cell lipid peroxidation and antioxidant system in chronic renal failure patients treated with recombinant human erythropoietin.
    Bozfakioglu S; Alptekin N; Seçkin S; Ark E; Koçak-Toker N
    Nephron; 1992; 61(2):228-9. PubMed ID: 1630552
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of amantadine on corneal endothelium in subjects with Parkinson's disease.
    Chang KC; Jeong JH; Kim MK; Wee WR; Lee JH; Jeon BS
    Ophthalmology; 2010 Jun; 117(6):1214-9. PubMed ID: 20153901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [H3-cholesterol distribution in the erythrocytes and serum lipoproteins in patients with chronic renal failure].
    Zdrojewski Z
    Pol Arch Med Wewn; 1984 Apr; 71(4):249-56. PubMed ID: 6483646
    [No Abstract]   [Full Text] [Related]  

  • 35. Alteration in red blood cell sodium and potassium concentrations and increased lipid peroxidation in patients with chronic renal failure on maintenance hemodialysis: a hypothesis.
    Paskalev D; Tchankova P; Jankova T; Steiner M; Nenov D
    Am J Nephrol; 1994; 14(3):246-8. PubMed ID: 7832914
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions of the antiviral and antiparkinson agent amantadine with lipid membranes and human erythrocytes.
    Suwalsky M; Jemiola-Rzeminska M; Altamirano M; Villena F; Dukes N; Strzalka K
    Biophys Chem; 2015 Jul; 202():13-20. PubMed ID: 25899993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased erythrocyte insulin receptor binding in diabetic man with chronic renal failure.
    Gambhir KK; Nerurkar SG; Cruz IA; Hosten AO
    Horm Metab Res; 1980 Aug; 12(8):414-5. PubMed ID: 6997168
    [No Abstract]   [Full Text] [Related]  

  • 38. Occurrence of adverse effects and high amantadine concentrations with influenza prophylaxis in the nursing home.
    Degelau J; Somani S; Cooper SL; Irvine PW
    J Am Geriatr Soc; 1990 Apr; 38(4):428-32. PubMed ID: 2329251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrocyte insulin receptors in chronic renal failure.
    Gambhir KK; Archer JA; Nerurkar SG; Cruz IA; Sanders M
    Nephron; 1981; 28(1):4-10. PubMed ID: 7266727
    [No Abstract]   [Full Text] [Related]  

  • 40. [Superoxide dismutase activity in erythrocytes and malondialdehyde levels in the erythrocytes and plasma at different periods of renal failure].
    Trznadel K; Pawlicki L; Kedziora J; Luciak M; Błaszczyk J; Buczyński A
    Pol Arch Med Wewn; 1988 Nov; 80(5):261-6. PubMed ID: 3271328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.